Guardian Capital (Canada)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-4,677
Closed -$432K 193
2019
Q2
$432K Sell
4,677
-1,709
-27% -$162K 0.01% 136
2019
Q1
$602K Buy
6,386
+1,656
+35% +$145K 0.01% 125
2018
Q4
$303K Sell
4,730
-1,130
-19% -$83.4K 0.01% 168
2018
Q3
$524K Buy
5,860
+3,135
+115% +$277K 0.01% 133
2018
Q2
$216K Buy
+2,725
New +$226K ﹤0.01% 170
2017
Q4
Sell
-3,560
Closed -$519K 216
2017
Q3
$519K Sell
3,560
-73
-2% -$9.94K 0.01% 154
2017
Q2
$472K Sell
3,633
-142
-4% -$17.4K 0.01% 162
2017
Q1
$470K Buy
3,775
+1,848
+96% +$221K 0.01% 161
2016
Q4
$223K Buy
+1,927
New +$215K ﹤0.01% 208
2015
Q1
Sell
-2,783
Closed -$311K 257
2014
Q4
$311K Buy
+2,783
New +$294K 0.01% 206
2013
Q4
Sell
-21,020
Closed -$1.62M 229
2013
Q3
$1.62M Sell
21,020
-260
-1% -$18.2K 0.03% 125
2013
Q2
$1.25M Buy
+21,280
New +$1.28M 0.02% 124

Other funds holding CELG

Guardian Capital (Canada)'s CELG Position: Q3 2019 in Review

Guardian Capital (Canada) sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 4,677 shares — an estimated $432K sold.

Guardian Capital (Canada) first reported a position in CELG in Q2 2013 and held it in 12 quarters. The position peaked at $1.62M in Q3 2013. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Guardian Capital (Canada) reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Guardian Capital (Canada) sold 4,677 Celgene Corp shares in Q3 2019, an estimated $432K.
  • Guardian Capital (Canada) first reported a position in Celgene Corp in Q2 2013 and held it in 12 quarters.
  • Guardian Capital (Canada)'s Celgene Corp position peaked at $1.62M in Q3 2013.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Guardian Capital (Canada)'s 13F filing for Q3 2019, filed 14 Nov 2019.